| Stage | BAX | % of rev | SYK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.0B | 100.00% | $6.5B | 100.00% | SYK ×2.19 |
| Gross profit | $994M | 33.40% | $4.2B | 65.15% | SYK +31.8pp |
| Operating income | $225M | 7.56% | $1.0B | 15.86% | SYK +8.3pp |
| Pre-tax income | $417M | 14.01% | $997M | 15.29% | SYK +1.3pp |
| Net income | $294M | 9.88% | $753M | 11.55% | SYK +1.7pp |
| Stage | BAX | SYK | Gap · A − B |
|---|---|---|---|
| Revenue | $3.0B100.00% | $6.5B100.00% | SYK ×2.19 |
| Gross profit | 33.40%$994M | 65.15%$4.2B | SYK +31.8pp |
| Operating income | 7.56%$225M | 15.86%$1.0B | SYK +8.3pp |
| Pre-tax income | 14.01%$417M | 15.29%$997M | SYK +1.3pp |
| Net income |
| 9.88%$294M |
| 11.55%$753M |
| SYK +1.7pp |
No shared counterparties.